Pinned Tweet
Excited to share that I’m officially applying for Cardiology Fellowship! Looking forward to the upcoming interview season. I’m incredibly grateful to the support from everyone up until this point.
AAMC ID: 16007586
#CardiologyFellowship #CardioTwitter #Match2027 #MedTwitter
AAMC ID: 16007586
#CardiologyFellowship #CardioTwitter #Match2027 #MedTwitter
6
5
51
3,416
Our new review on bempedoic acid in statin intolerance is out! We explore evidence beyond CLEAR Outcomes and practical implementation.
Grateful to learn from and collaborate with outstanding mentors @CarlosVergaraMD and @DrMichaelShapir.
rdcu.be/HAWBqp62PBoa
Grateful to learn from and collaborate with outstanding mentors @CarlosVergaraMD and @DrMichaelShapir.
rdcu.be/HAWBqp62PBoa
2
3
21
1,249
Rodolfo Lopes retweeted
🫀 Redefining Cardiology: Evolving Definitions. Everyday Clinical Decisions.
Join us for @FloridaACC FIT’s interactive, case-based series exploring the latest in cardiology with leading experts! Proud to lead this initiative as FIT Medical Education Chair in collaboration with Heart Failure – Beyond EF
🔹 Dec 8: MI – Clarifying the Diagnosis
⏰ 6:30 PM ET | 💻 Virtual
🔗 Cardioedu.com/Redefining-Car…
#FloridaACC #ACCFIT @ACCinTouch #CardiologyEducation #HeartFailure #MyocardialInfarction #MedEd
Join us for @FloridaACC FIT’s interactive, case-based series exploring the latest in cardiology with leading experts! Proud to lead this initiative as FIT Medical Education Chair in collaboration with Heart Failure – Beyond EF
🔹 Dec 8: MI – Clarifying the Diagnosis
⏰ 6:30 PM ET | 💻 Virtual
🔗 Cardioedu.com/Redefining-Car…
#FloridaACC #ACCFIT @ACCinTouch #CardiologyEducation #HeartFailure #MyocardialInfarction #MedEd
0
15
15
1,302
Rodolfo Lopes retweeted
A must-see event with @DrMichaelShapir
Join us Oct 29 at 8am CT for a Grand Rounds conference featuring Michael D. Shapiro, DO presenting “From Evidence to Action: Key Updates in the New Dyslipidemia Guideline Every Cardiologist Should Know.”
Watch LIVE: bit.ly/GR102926
#DeBakyCVEdu #GrandRounds
0
1
3
164
❤️ A patient now meets criteria for biomarker-defined pre-HF. What should change in care?
Following the study Drs. @sohailszahid & @MichaelJBlaha share an exciting editorial @AJPCardio “The Signal Before the Syndrome,” focusing on the clinical decisions that come next.
Following the study Drs. @sohailszahid & @MichaelJBlaha share an exciting editorial @AJPCardio “The Signal Before the Syndrome,” focusing on the clinical decisions that come next.
1
3
11
472
8/ A screening strategy should be judged by its consequences.
The editorial calls for evidence on effectiveness, risks, feasibility and cost-effectiveness, including effects on quality of life and mortality.
Those outcomes should guide the next phase.
The editorial calls for evidence on effectiveness, risks, feasibility and cost-effectiveness, including effects on quality of life and mortality.
Those outcomes should guide the next phase.
1
1
1
180
9/ ✍️The takeaway: how to pair pre-HF detection with a practical plan for care?
Thank you to author for this insightful discussion.
Read Full Text: doi.org/10.1016/j.ajpc…
@AJPCardio @khurramn1
#HeartFailure #Prevention #CKM
Thank you to author for this insightful discussion.
Read Full Text: doi.org/10.1016/j.ajpc…
@AJPCardio @khurramn1
#HeartFailure #Prevention #CKM
1
1
1
149
❤️Are we missing pre-heart failure when we rely on echo alone?
A pooled analysis of 11,426 adults examines what cardiac biomarkers add to Stage B identification and HF risk prediction.
@AJPCardio
A pooled analysis of 11,426 adults examines what cardiac biomarkers add to Stage B identification and HF risk prediction.
@AJPCardio
1
4
9
566
11/ ⚠️ Important limitations
• Observational design
• Single time point baseline measurements
• Different assays and incomplete echo measures across cohorts
• Selected analytic population
➡️ The study did not test whether treating biomarker-defined pre-HF prevents HF.
• Observational design
• Single time point baseline measurements
• Different assays and incomplete echo measures across cohorts
• Selected analytic population
➡️ The study did not test whether treating biomarker-defined pre-HF prevents HF.
1
0
0
19
12/ ❤️ Key message
Biomarkers may identify pre-HF risk missed by echo-only staging.
Biomarker + echo abnormalities mark the highest-risk group.
Congratulations to the authors @NeilKeshvani @ambarish4786 and team!
Full Text Link: sciencedirect.com/science/articl…
#HeartFailure
Biomarkers may identify pre-HF risk missed by echo-only staging.
Biomarker + echo abnormalities mark the highest-risk group.
Congratulations to the authors @NeilKeshvani @ambarish4786 and team!
Full Text Link: sciencedirect.com/science/articl…
#HeartFailure
0
0
1
22